Ensysce Biosciences, Inc.
Pharmaceutical Preparations · LA JOLLA · CA
Moderate confidence (50%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Ensysce Biosciences, Inc. received a delisting notice from its exchange (May 22, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Ensysce Biosciences, Inc. received a delisting notice from its exchange
May 22, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing On May 21, 2026, Ensysce Biosciences Inc. (the Company ) received notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) stating that due to the Company s non-compliance with the $2.5 million stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) as of March 31, 2026, the Company is subject to delisting unless it submits a plan within 45 days (by July 6, 2026) to regain compliance. If the plan is accepted, the Company may be grant…”
Ensysce Biosciences, Inc. received a delisting notice from its exchange
Feb 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard On February 25, 2026, Ensysce Biosciences Inc. (the Company ) received a notice (the Deficiency Letter ) from the listing qualifications department staff of The Nasdaq Stock Market ( Nasdaq ) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company s common stock had closed below $1.00 per share for the previous 30 consecutive business days. Nasdaq requires that Ensysce common stock have a minimum bid price of at least $1 per share (the Minimum…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ENSC on Nasdaq.
- SEC CIK
- 0001716947
- Website
- —
- —
- Headquarters
- LA JOLLA, CA
- Also known as
- Leisure Acquisition Corp.
- Legal entities
- Ensysce Biosciences, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Ensysce Biosciences, Inc. — Pharmaceutical Preparations (SIC 2834) — LA JOLLA, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing On May 21, 2026, Ensysce Biosciences Inc. (the Company ) received notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) stating that due to the Company s non-compliance with the $2.5 million stockholders equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) as of March 31, 2026, the Company is subject to delisting unless it submits a plan within 45 days (by July 6, 2026) to regain compliance. If the plan is accepted, the Company may be grant…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard On February 25, 2026, Ensysce Biosciences Inc. (the Company ) received a notice (the Deficiency Letter ) from the listing qualifications department staff of The Nasdaq Stock Market ( Nasdaq ) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company s common stock had closed below $1.00 per share for the previous 30 consecutive business days. Nasdaq requires that Ensysce common stock have a minimum bid price of at least $1 per share (the Minimum…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.